BioSpace News Archive

Drug Development

ACELYRIN, INC., Affibody AB, and Inmagene Bio Announce Positive Results from Global Phase 2 Trial of Izokibep in Patients with Psoriatic Arthritis

ACELYRIN, INC., Affibody AB, and Inmagene Biopharmaceuticals Co., Ltd., announced that a 16-week, global, Phase 2 clinical trial of izokibep in 135 patients with psoriatic arthritis met its primary endpoint of ACR50.

May 3, 2022
·
5 min read
Pharm Country

Allelica Collaborates with Invitae to Build Ancestry-Informed Polygenic Risk Score for Breast Cancer

Allelica has formalized a partnership with Invitae Corporation, a leading medical genetics company, to build a clinical artificial intelligence architecture for breast cancer polygenic risk score development and clinical implementation in multiple ancestries.

May 3, 2022
·
4 min read
Deals

CenExel Acquires iResearchPremier CNS-Focused Research Facilities in Georgia Join the CenExel Centers of Excellence Clinical Research Site Network

CenExel announces the acquisition of iResearch (“CenExel iResearch”), a leading multi-specialty research site business with locations in Decatur, GA and Savannah, GA. .

May 3, 2022
·
4 min read
Pharm Country

UPDATE - Passage Bio to Present Updated Imagine-1 Study Clinical and Biomarker Data at the American Society of Gene and Cell Therapy 25th Annual Meeting

Passage Bio, Inc. announced that additional clinical and biomarker data from Cohort 1 in the Imagine-1 study for GM1 gangliosidosis will be presented at the upcoming American Society of Gene and Cell Therapy 25th Annual Meeting, which is being held in Washington, D.C. and virtually on May 16-19, 2022.

May 3, 2022
·
2 min read
Biologics Market to Garner Growth 7.8% by 2030

According to the report, the global biologics market size is expected to worth around US$ 719.84 billion by 2030 and is projected to expand at a CAGR of 7.8% from 2022 to 2030.

May 3, 2022
·
5 min read
Nanomedicine Market Size to Surpass US$ 866.26 Billion by 2029

According to Report, the global nanomedicine market size is expected to surpass around US$ 866.26 billion by 2029 from valued at US$ 377.37billion in 2021 and expanding growth at a CAGR of 11% from 2022 to 2030.

May 3, 2022
·
5 min read
Anatomic Pathology Market Size to Hit US$ 40.66 Bn by 2030

The global anatomic pathology market size is expected to hit around US$ 40.66 billion by 2030 from valued at US$ 17.06 billion in 2020 with a CAGR of 11.08% during forecast period 2021 to 2030.

May 3, 2022
·
3 min read
Cryotherapy Market Size to Hit US$ 10.4 Billion in 2030

The global Cryotherapy market size is expected to hit around US$ 10.4 billion by 2030 and is projected to grow at a CAGR of 20.3% during forecast period 2021 to 2030.

May 3, 2022
·
6 min read
Biopharmaceutical CMO and CRO Market Size to Hit US$ 60.1 BN by 2030

The global biopharmaceutical CMO and CRO market was valued at USD 30.1 billion in 2020 and is expected to rake around USD 60.1 billion by 2030 with a CAGR of 7.6% during the forecast period 2022 to 2030.

May 3, 2022
·
4 min read
Caeregen Therapeutics Announces Data Presentation at the Association for Research in Vision and Ophthalmology (ARVO) 2022 Annual Meeting

Caeregen Therapeutics, LLC, a Michigan-based, regenerative medicine therapeutics company today announced data on Noregen™ from studies conducted with the Oakland University Eye Research Institute (ERI), at the Association for Research in Vision and Ophthalmology (ARVO) 2022 Annual Meeting in Denver, CO.

May 3, 2022
·
4 min read